CEO
Nano PharmaSolutions
San Diego, California
Dr. Kay Olmstead (Ph.D./MBA, CEO/Founder) of Nano PharmaSolutions, Inc. (San Diego, CA) is a seasoned pharmaceutical development scientist with 30+ years of CMC (chemistry, manufacturing, and control) and regulatory/quality experience. She has 14 allowed patents, six of which have been approved by the FDA and/or EMA. Her search for reliable enabling technology for small molecule drug oral dosage forms have led to invention of physical nanotechnology for drug development which uses no chemicals or solvents to generate drug nanoparticles. She is a strong proponent of using the essentially same formulation of dosage forms from the preclinical animal safety studies to first-in-human and Phase II/III clinical studies to improve the success rate of each development stages. Dr. Olmstead received a Ph.D. degree in Organic Chemistry from the Johns Hopkins University and performed the post-doctoral research at Stanford University. She also received an MBA degree with emphasis in Quality Systems Management from San Diego State University.
Disclosure information not submitted.
Monday, October 17, 2022
9:00 AM – 9:30 AM ET